2018
DOI: 10.1007/s10143-018-0994-5
|View full text |Cite
|
Sign up to set email alerts
|

Progress in moyamoya disease

Abstract: Moyamoya disease is characterized by progressive stenosis or occlusion of the intracranial portion of the internal carotid artery and their proximal branches, resulting in ischemic or hemorrhagic stroke with high rate of disability and even death. So far, available treatment strategies are quite limited, and novel intervention method is being explored. This review encapsulates current advances of moyamoya disease on the aspects of epidemiology, etiology, clinical features, imaging diagnosis and treatment. In a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
96
0
5

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 95 publications
(102 citation statements)
references
References 104 publications
1
96
0
5
Order By: Relevance
“…Moyamoya disease is a rare, non-atherosclerotic arteriopathy characterised by progressive stenosis of the internal carotid arteries, ultimately leading to occlusion 15. The prevalence of moyamoya disease is higher in children and young adults than those aged 50 years or over and varies widely worldwide.…”
Section: Epidemiology and Stroke Aetiology From A Global Perspectivementioning
confidence: 99%
“…Moyamoya disease is a rare, non-atherosclerotic arteriopathy characterised by progressive stenosis of the internal carotid arteries, ultimately leading to occlusion 15. The prevalence of moyamoya disease is higher in children and young adults than those aged 50 years or over and varies widely worldwide.…”
Section: Epidemiology and Stroke Aetiology From A Global Perspectivementioning
confidence: 99%
“…The smoke‐like vessels are fragile and thin, resulting in thrombosis formation and microaneurysm rupture, leading to cerebral ischemia and hemorrhage . Furthermore, lack of adequate blood flow can lead to cortical and subcortical ischemia, resulting in neurological deficits . Hence, improvement and restoration of CBF in moyamoya is a topic of ongoing interest.…”
Section: Discussionmentioning
confidence: 99%
“…Chronic cerebral circulation insufficiency in iMMD always causes nonfocal neurological deficits such as headache, dizziness, and insomnia; as a result, the subjective feelings from patients are of great importance. Therefore, PGIC scales, which reflected the emotional and patient‐subjective status, were used as the indicator for symptom amelioration in this study . Of the 30 patients, 29 noticed a benefit from RIC, while one patient experienced a minor stroke recurrence and his symptoms mildly fluctuated during the follow‐up period.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have investigated genetic, acquired, and environmental factors as causes of moyamoya disease, but no specific cause has yet been found (Shang et al, 2020). Vasodilator, anticoagulant, and hemostatic treatments are typically used, but there is no standard clinical treatment available, and while surgical methods such as direct and indirect revascularization are often used, medical professionals have not reached a consensus regarding the best options for adults with moyamoya disease (Ding et al, 2018; Ge et al, 2017).…”
Section: Introductionmentioning
confidence: 99%